Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR® (deutetrabenazine) extended-release tablets Patients…Read More
You might also be interested in reading Invesco DWA Emerging Markets Momentum ETF declares quarterly distribution of $0.0809.